bmy 21502 has been researched along with Aging in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Coffin, JM; Haunton-Kreps, M; Moon, SL; Sasse, DK; Woodruff-Pak, DS | 1 |
| Bauman, LA; Gribkoff, VK; VanderMaelen, CP | 1 |
2 other study(ies) available for bmy 21502 and Aging
| Article | Year |
|---|---|
Effect of BMY 21502 on classical conditioning of the eyeblink response in young and older rabbits.
Topics: Aging; Alzheimer Disease; Animals; Blinking; Conditioning, Classical; Female; Male; Phorbol 12,13-Dibutyrate; Protein Kinase C; Pyrimidines; Pyrrolidinones; Rabbits | 1991 |
A 1-heteroaryl-4-piperidinyl-methyl pyrrolidinone, BMY 21502, delays the decay of hippocampal synaptic potentiation in vitro.
Topics: Aging; Animals; Hippocampus; In Vitro Techniques; Neurons; Psychotropic Drugs; Pyramidal Tracts; Pyrimidines; Pyrrolidinones; Rats; Rats, Inbred Strains; Synapses; Time Factors | 1990 |